Asieris Pharmaceuticals Enters an Exclusive Licensing Agreement with Theramex for CEVIRA® subject to certain conditions, Advancing the Global Development and Commercialization of a Non-Surgical Treatment for Cervical Precancerous Lesions...
Agreement is expected to grant Theramex exclusive rights to CEVIRA® in Europe, Australia, New Zealand and Turkey, while Asieris retains rights for the rest of the world. The deal includes 15 million US dollars of upfront payment and a total of 11 million dollars of near-term regulatory milestone payments，and commercial milestone payments as well as tiered royalties....
Resonant Clinical Solutions and Haier Biomedical Introduce an Innovative Benchtop Centrifuge with a Natural Refrigerant
Exclusive partnership results in a user-centric, hydrocarbon-cooled centrifuge purpose-built for clinical trials – years ahead of upcoming F-gas regulatory changes in Europe and the U.S. LEESBURG, Va. and QINGDAO, China, Oct. 7, 2026 /PRNewswire/ -- Resonant Clinical Solutions – a global clinical solutions partner serving life sciences organizations across the clinical supply chain and sample lifecycle – and Haier...
Flat Medical Surpasses 30 U.S. Hospitals and Pain Centers Using the EpiFaith® Smart Syringe in Routine Clinical Practice
Adoption spans obstetric anesthesia and interventional pain management, as major integrated delivery networks begin groundwork for system-wide conversion AUSTIN, Texas, Oct. 7, 2026 /PRNewswire/ -- Flat Medical, a provider of precision needle access and guidance solutions for anesthesia, critical care, and pain management, today announced that more than 30 hospitals and pain management centers across the United States...
LG CNS Showcases Pharma-Specific Manufacturing AX at World’s Largest Pharma-Biotech Show
Participates in CPHI Milan 2026, Expanding Manufacturing AX Reach in Pharma Showcasing key solutions for factory design, production operations, and quality management using the theme "Autonomous Factory in Pharma" SEOUL, South Korea and MILAN, Oct. 7, 2026 /PRNewswire/ -- LG CNS, a leading AI Transformation company in Korea, is expanding its manufacturing AX business with a showcase of...
OncoBayes progressing OB-001 to tackle ADC resistance and TKI brain penetration
LONDON, Oct. 7, 2026 /PRNewswire/ -- OncoBayes, a privately held clinical-stage pharmaceutical company, today announced the successful completion of preclinical work with OB-001, demonstrating the product's potential to tackle two major unmet needs in oncology: ADC resistance and the brain penetration of tyrosine kinase inhibitors (TKIs). OB-001 is a highly selective and effective inhibitor of two key efflux...
Let the Light Be Heard: LifeWave Taiwan Marks Fourth Year with SimplyICR as Nearly 60 Participants Find Their Rhythm Through Tap Dance
TAIPEI, Oct. 7, 2026 /PRNewswire/ -- Light can be seen. But what would it sound like if light could also be heard? Through its “Hearts to Hearts” community initiative, LifeWave Taiwan continues to put its belief in each individual’s potential and value into action, creating opportunities for more people to be seen for who they are and...
Cambridge Heartwear Awarded £184 Million NHS Tender for World’s First Medical-Grade, Wirelessly Charged, Reusable ECG Wearable
CAMBRIDGE, England, Oct. 7, 2026 /PRNewswire/ -- Cambridge Heartwear® Limited (www.camheartwear.com) has secured a landmark £184 million tender with the National Health Service (NHS) of the UK for HeartSense®, the world's first medical-grade, multi-channel, portable, wirelessly charged ECG wearable straight to one's mobile phone, representing a significant advancement in global Medical technology, AI application and cardiovascular diagnostics. Cambridge Heartwear Awarded £184 Million NHS Tender for...
XtalPi Debuts Kodexia™, the World’s First Closed-Loop siRNA Platform Combining Generative AI with First-Principles Modeling
This unified platform integrates sequence design, chemical modification, experimental validation, extrahepatic delivery design, and intellectual property strategy into an integrated computational–experimental workflow, pioneering in vivo efficacy prediction models to accelerate drug development. Validating this infrastructure, XtalPi announced the advancement of six proprietary preclinical programs targeting complex diseases, with the first...
Hisun Pharmaceutical Celebrates 70th Anniversary with Global Partners at Milan-Taizhou Night
MILAN, Oct. 6, 2026 /PRNewswire/ -- Zhejiang Hisun Pharmaceutical Co., Ltd. hosted its 70th Anniversary Global Partners Appreciation Dinner in Milan on October 5, the eve of CPHI Milan 2026. Themed "Bridging Cultures, Advancing Health Together," the event brought together leading pharmaceutical companies from around the world for an evening of networking and cultural exchange. Mr. Geng Xiewei,...
ZEISS demonstrates new digital and visual enhancements across ophthalmic workflows at AAO
ZEISS Medical Technology will showcase its latest innovations and digital technologies at AAO, including: Connected cataract workflow –ZEISS VERACITY Surgery Planner reaches 3 million surgical cases planned through cloud-based software, supporting surgical efficiency built on automation and accurate data. Excellent surgical ergonomics – The HMDmd CR3 head-mounted 3D digital display...
